Patents Assigned to Flagship Pioneering Innovations V, Inc.
-
Patent number: 11974574Abstract: Provided herein are methods and compositions for modulating the fitness of a host invertebrate (e.g., insect, mollusk, or nematode) by altering interactions between the host and one or more micoorganisms resident in the host. The invention features a composition including a modulating agent (e.g., a polypeptide, nucleic acid, small molecule, or combinations thereof) that can induce changes in the host's microbiota in a manner that modulates (e.g., increases or decreases) host fitness. The modulating agent described herein may modulate the fitness of a variety of invertebrates that are important for agriculture, commerce, and/or public health.Type: GrantFiled: February 23, 2018Date of Patent: May 7, 2024Assignee: Flagship Pioneering Innovations V, Inc.Inventors: Ignacio Martinez, Zachary Garo Armen, Barry Andrew Martin, Maier Steve Avendano Amado
-
Patent number: 11951154Abstract: The present disclosure described herein provides compositions with a membrane-penetrating properties and methods for allowing translocation across a membrane without disruption.Type: GrantFiled: June 8, 2022Date of Patent: April 9, 2024Assignee: FLAGSHIP PIONEERING INNOVATIONS V, INC.Inventors: Laura Gabriela Lande, David Arthur Berry
-
Patent number: 11903975Abstract: Therapeutic chondrisome and mitoplast compositions and related methods are described.Type: GrantFiled: November 30, 2016Date of Patent: February 20, 2024Assignees: FLAGSHIP PIONEERING INNOVATIONS V, INC., The Children's Medical Center CorporationInventors: Geoffrey A. von Maltzahn, John Miles Milwid, Michael Travis Mee, Jacob Rosenblum Rubens, David Chess, Kyle Marvin Trudeau, Kiana Mahdaviani, Jacob Feala, James D. McCully, Douglas B. Cowan
-
Patent number: 11903974Abstract: Therapeutic chondrisome compositions and related methods are described.Type: GrantFiled: November 30, 2016Date of Patent: February 20, 2024Assignees: FLAGSHIP PIONEERING INNOVATIONS V, INC., The Children's Medical Center CorporationInventors: Geoffrey A. von Maltzahn, John Miles Milwid, Michael Travis Mee, Jacob Rosenblum Rubens, David Chess, Kyle Marvin Trudeau, Kiana Mahdaviani, Jacob Feala, James D. McCully, Douglas B. Cowan
-
Patent number: 11859219Abstract: Disclosed herein are compositions and methods for effecting alterations at a defined location in the genome of a plant cell or plant protoplast. Further disclosed are methods using an RNA-guided nuclease to alter a target nucleotide sequence in a cell or protoplast of a plant; embodiments of such methods include treatments with chemical or physical reagents or treatment of the cell or protoplast with a specific thermal regime, such as a heat treatment.Type: GrantFiled: December 29, 2017Date of Patent: January 2, 2024Assignee: Flagship Pioneering Innovations V, Inc.Inventors: Yajie Niu, Kristine Yu, Frank Anthony Skraly, Randall William Shultz, John P. Casey, Jr., Brian Prescott Fiske
-
Patent number: 11813272Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.Type: GrantFiled: November 17, 2020Date of Patent: November 14, 2023Assignee: Flagship Pioneering Innovations V, Inc.Inventors: Steven John Taylor, John Robert Proudfoot, Mi-Jeong Kim, Kathleen Nudel, Timothy F. Briggs, Afrand Kamali Sarvestani, Leonard Buckbinder, Bernard Lanter, Ferdinand Edward Massari, Koji Yasuda, Spencer Cory Peck, Cheri Snedeker, Diana Le, Jessica Alexander, Anna Liang, Dinara Gunasekera, David Arthur Berry, John Patrick Casey, Jr.
-
Patent number: 11690387Abstract: Provided herein are methods and compositions for food and feed applications, e.g., for targeting one or more microorganisms resident in a host insect, the modulation resulting in an increase in the fitness of the host. The invention features a composition that includes a modulating agent (e.g., phage, peptide, small molecule, antibiotic, or combinations thereof) that can alter the host's microbiota in a manner that is beneficial to the host. By promoting favorable microbial levels, microbial activity, microbial metabolism, and/or microbial diversity, the modulating agent described herein may be used to increase the fitness of a variety of insects utilized in human food or animal feed industries.Type: GrantFiled: January 24, 2018Date of Patent: July 4, 2023Assignee: Flagship Pioneering Innovations V, Inc.Inventors: Ignacio Martinez, Zachary Garo Armen, Christine Cezar, Barry Andrew Martin, Maier Steve Avendano Amado
-
Patent number: 11624065Abstract: The present disclosure provides compositions with a modulating gene expression and methods for modulating transcription.Type: GrantFiled: October 9, 2018Date of Patent: April 11, 2023Assignee: FLAGSHIP PIONEERING INNOVATIONS V, INC.Inventors: Laura Gabriela Lande, David Arthur Berry, Rahul Karnik
-
Patent number: 11576872Abstract: In some aspects, fusosome compositions and methods are described herein that comprise membrane enclosed preparations, comprising a fusogen. In some embodiments, the fusosome can the target cell, thereby delivering complex biologic agents to the target cell cytoplasm.Type: GrantFiled: May 8, 2018Date of Patent: February 14, 2023Assignee: FLAGSHIP PIONEERING INNOVATIONS V, INC.Inventors: Geoffrey A. von Maltzahn, John Miles Milwid, Michael Travis Mee, Jacob Rosenblum Rubens, Nathan Wilson Stebbins, Molly Krisann Gibson, Neal Francis Gordon, Bo Zhang, Kyle Marvin Trudeau, Brigham Jay Hartley, Tamar Rose Putiri, Kiana Mahdaviani, Matthew Milnes Dobbin
-
Patent number: 11471433Abstract: Disclosed herein are compositions and methods for increasing the fitness of insects for agriculture or commerce, wherein the composition includes a postbiotic agent (e.g., a short chain fatty acid).Type: GrantFiled: July 31, 2020Date of Patent: October 18, 2022Assignee: Flagship Pioneering Innovations V, Inc.Inventors: Ignacio Martinez, Maier Steve Avendano Amado, Thomas Michael Malvar, Emily Michelle Mallick
-
Patent number: 11446344Abstract: This invention relates generally to viral vectors and viral particles based on Anelloviruses, which can be used to deliver an agent (e.g., an exogenous effector or an endogenous effector, e.g., a therapeutic effector) to a cell (e.g., a cell in a subject to be treated therapeutically). Described herein are anellosomes, anellovectors, and compositions and uses thereof.Type: GrantFiled: September 29, 2021Date of Patent: September 20, 2022Assignee: FLAGSHIP PIONEERING INNOVATIONS V, INC.Inventors: Simon Delagrave, Fernando Martin Diaz, Avak Kahvejian, Kevin James Lebo, Dhananjay Maniklal Nawandar, Jared David Pitts, Ryan D. Tedstone, Erica Gabrielle Weinstein, Nathan Lawrence Yozwiak
-
Publication number: 20220249625Abstract: Provided are compositions comprising an endonuclease and methods for purifying an endonuclease. One aspect of the invention provides a composition comprising at least 100 mg of an untagged endonuclease having an A260/A280 absorbance ratio of from about X to about 0.8, wherein X is less than 0.8. Another aspect of the invention provides a composition, generated by contacting a composition comprising at least 100 mg of an untagged endonuclease having an A260/A280 absorbance ratio of from about X to about 0.8, wherein X is less than 0.8, with an endonuclease binding molecule, wherein the endonuclease and the endonuclease binding molecule form a protein effector.Type: ApplicationFiled: January 29, 2020Publication date: August 11, 2022Applicant: Flagship Pioneering Innovations V, Inc.Inventors: Jennifer Louise Schmitke, Robert John Lyng, Carol Chan
-
Patent number: 11382950Abstract: The present disclosure described herein provides compositions with a membrane-penetrating properties and methods for allowing translocation across a membrane without disruption.Type: GrantFiled: November 1, 2017Date of Patent: July 12, 2022Assignee: FLAGSHIP PIONEERING INNOVATIONS V, INC.Inventors: Laura Gabriela Lande, David Arthur Berry
-
Patent number: 11376272Abstract: In one aspect, the invention provides methods of increasing immune response by administering postcellular signaling factors produced by cells exposed to a stress condition. In one aspect, the invention provides methods of increasing immune response by administering in combination (a) a Stimulator of Interferon Genes (STING) agonist and (b) a purinergic receptor agonist. The increase in immune response may be used, for example, for treatment of infection or cancer. The invention also provides screening assays for identification of compounds that induce production of postcellular signaling factors which are also immunostimulatory agents. The invention further provides methods for identifying postcellular signaling factors with immunostimulatory activity. In another aspect, the invention provides methods of decreasing immune response by administering to a cell, tissue or subject a purinergic receptor antagonist alone or in combination with a Stimulator of Interferon Genes (STING) antagonist.Type: GrantFiled: May 6, 2021Date of Patent: July 5, 2022Assignee: Flagship Pioneering Innovations V, Inc.Inventors: Anthony Michael Barsotti, Alexandra Masu Cantley, Jason Park, Douglas Gowers Cole
-
Patent number: 11350648Abstract: Provided herein are agents, compositions, and methods for agricultural use, e.g., for altering the level, activity, or metabolism of one or more microorganisms resident in a host nematode or arthropod (e.g., honeybee or silkworm), the alteration resulting in an increase in the fitness of the host. The invention features a composition that includes an agent (e.g., phage, peptide, small molecule, antibiotic, or combinations thereof) that can alter the host's microbiota in a manner that is beneficial to the host. By promoting favorable microbial levels, microbial activity, microbial metabolism, and/or microbial diversity, the agents described herein may be used to increase the fitness of a variety of beneficial nematodes or arthropods, such as bees and silkworms, utilized in agriculture and commerce.Type: GrantFiled: January 24, 2018Date of Patent: June 7, 2022Assignee: Flagship Pioneering Innovations V, Inc.Inventors: Ignacio Martinez, Zachary Garo Armen, Jonathan Friedlander, Christine Cezar, Barry Andrew Martin, Maier Steve Avendano Amado
-
Patent number: 11312955Abstract: The present disclosure provides compositions with a modulating gene expression and methods for modulating transcription.Type: GrantFiled: November 22, 2017Date of Patent: April 26, 2022Assignee: FLAGSHIP PIONEERING INNOVATIONS V, INC.Inventors: David Arthur Berry, Rahul Karnik, Laura Gabriela Lande
-
Publication number: 20220098574Abstract: One aspect of the invention provides a method of separating long polynucleotides from a composition. The method includes: introducing a composition including one or more long polynucleotides into a container including at least one boundary defined by a filter comprising a plurality of pores, wherein the pores have a smaller cross-sectional dimension than specified for the long polynucleotide's molecular weight; and applying elevated hydraulic pressure to the composition, thereby causing at least some of the one or more long polynucleotides to pass through the pores.Type: ApplicationFiled: January 29, 2020Publication date: March 31, 2022Applicant: Flagship Pioneering Innovations V, Inc.Inventors: Jennifer Louise Schmitke, Robert John Lyng, Vishwesh Ashok Patil, Can Sarisozen, Marcus Ian Gibson
-
Patent number: 11274158Abstract: The present invention provides methods for treating inflammatory or autoimmune disease using calcitonin receptor activators, such as calcitonin receptor activating antibodies, among others. The invention also features compositions containing calcitonin receptor activators, methods of diagnosing patients with calcitonin receptor-associated inflammatory or autoimmune disease, and methods of predicting the response of an inflammatory or autoimmune disease or condition in a subject to treatment with calcitonin receptor activators.Type: GrantFiled: September 24, 2018Date of Patent: March 15, 2022Assignee: Flagship Pioneering Innovations V, Inc.Inventors: Avak Kahvejian, Jordi Mata-Fink, Jonathan Barry Hurov, Chengyi Jenny Shu, George Huck Neubauer, Manuel Andreas Fankhauser, Julian Alexander Stanley
-
Patent number: 11208475Abstract: The present invention provides methods for treating inflammatory or autoimmune diseases or conditions using serotonin receptor activators, such as serotonin receptor activating antibodies, among others. The invention also features compositions containing serotonin receptor activators, methods of diagnosing patients with a serotonin receptor-associated inflammatory or autoimmune disease or condition, and methods of predicting the response of an inflammatory or autoimmune disease or condition in a subject to treatment with serotonin receptor activators.Type: GrantFiled: January 30, 2019Date of Patent: December 28, 2021Assignee: Flagship Pioneering Innovations V, Inc.Inventors: Avak Kahvejian, Jordi Mata-Fink, Jonathan Barry Hurov, Chengyi Jenny Shu, George Huck Neubauer, Manuel Andreas Fankhauser, Julian Alexander Stanley
-
Publication number: 20210353543Abstract: Provided herein are lipid particles containing a lipid bilayer enclosing a lumen or cavity, a henipavirus F protein molecule or biologically active portion thereof, and a targeted envelope protein containing a henipavirus envelope attachment glycoprotein G (G protein) or biologically active portion thereof and a binding domain, such as a single domain antibody (sdAb) variable domain. Also provided herein are targeted envelope proteins containing a G protein fused or linked to a binding domain, such as a sdAb variable domain, and polynucleotides encoding such proteins. Also provided are producer cells and compositions containing such targeted lipid particles and methods of making and using the targeted lipid particles.Type: ApplicationFiled: March 30, 2021Publication date: November 18, 2021Applicants: Sana Biotechnology, Inc., Flagship Pioneering Innovations V, Inc.Inventors: Kyle Marvin TRUDEAU, Christopher BANDORO, Lauren Pepper MACKENZIE, Jagesh Vijaykumar SHAH, Geoffrey A. VON MALTZAHN, Jacob Rosenblum RUBENS, Michael Travis MEE